Impellam (#IPEL) – recommended offer of 557.2p and 392.8p in loan notes per share

Impellam (#IPEL) – FY adj. EPS up to 32.6p, notes currently some permanent hiring hesitancy

Impellam (#IPEL) – FY adj. EPS up to 18.6p, “to re-commence the payment of annual dividends”

Impellam (#IPEL) – expects 2022 “ahead of its original expectations”, agreement to sell Regional Specialist Staffing and Healthcare Staffing businesses for £85m

Impellam (#IPEL) – Q1 “strong trading”, appointed Houlihan Lokey as financial adviser as potential sale explored

Impellam (#IPEL) – with annual report release, Lord Ashcroft notifies to explore selling majority interest

Impellam (#IPEL) – completes disposal of US-based light industrial staffing business Corestaff

Impellam – agrees disposal to add to “positive momentum”, but bank big gains?

Staffing group Impellam (IPEL) has announced it has agreed to sell its US-based light industrial business Corestaff for $19 million (approx. £14 million) to US private digital staffing company Swipejobs and is to subsequently pay down net debt and fund additional investment.

Impellam – half-year results, recovery but more to come?

International staffing group Impellam (IPEL) has announced results for the first half of the year and that it is seeing “increasing positivity in our customer demands for our managed service and talent solutions across our markets”. This sounds encouraging.

Impellam Group – a recovery buy?

The latest results from staffing group Impellam (IPEL) included it emphasising “we are well placed to take advantage of a return to growth”. We have longer-term macroeconomic concerns, added to by the response to Covid-19, but do accept there is strong upcoming macroeconomic recovery potential. Many stocks in the recruitment sector have already responded, doubling and much more but here a current 294p to buy compares to a low of 220p and we see recovery potential back to 375p+. That makes the shares a recovery buy.

Impellam – full-year results argue “our strategy is working”. Is it?

Recruitment and managed services group Impellam (IPEL) has announced full-year results, including emphasising “Our strategy is working with revenues increasing by 4.9% (5.7% at constant exchange rates)”… The shares have responded currently to 460p – 16% lower!...

Impellam (#IPEL) – FY adj. EPS -24%, “expect to see a return to higher levels of conversion of gross profit”

Impellam (#IPEL) – to de-merge Carlisle Support Services via a dividend in specie to shareholders

Impellam – starts with Managed Services “ahead of expectations”… but it’s a profit warning!

A trading statement from staffing and managed services company Impellam (IPEL) commences that “Impellam continues to make good strategic progress. Our Managed Services businesses in the UK and Australia are growing ahead of expectations as is the entire US business, on a like for like currency basis”. Sounds good then. The shares?... Er, currently down approaching 20% at around 500p!...

Impellam (#IPEL) – warns due to Healthcare, UK retail and exchange rate adversities

I Impel 'Em to Look at Impellam, If They Want to Invest in a Company that May Be Just the Job

Hello, Share Bunnies. A long time ago, I dumped my shares in Impellam (IPEL) though I think my wife may still be a holder. I recall that I followed some advice on this beautiful website to part company with this across-the-board recruitment agency. They'd had a good run and so I made a handsome profit. But the company seemed to be running out of steam. Yet if I were commended to buy the share today, I might do so on the latest results.

Impellam (#IPEL) – H1 adj. EPS -16%, share buyback programme instead of dividend

Impellam (#IPEL) – expects 2016 EBITDA “broadly in line” (i.e. slightly behind), notes “prevailing uncertainty in the UK”

Impellam (#IPEL) bullish Q1 trading update, though greedy Doctors strike didnt help

Impellam (#IPEL) says will hit FY PTP forecast but debt looks high at £121m. Appoints new broker - placing ahoy?